Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYou do not need your GP's permission to start Mounjaro through a private clinic or pharmacy. As a prescription-only medicine, Mounjaro requires a prescription from a registered prescriber — but that prescriber does not have to be your GP, and no law compels you to inform your surgery before you begin. That said, there are good clinical reasons why most responsible services will notify your GP on your behalf, and understanding what those reasons are can help you make a confident, informed choice about how you start treatment. These are prescription-only medicines that require a proper clinical assessment; the prescriber reviewing your case decides whether treatment is appropriate for you personally.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Mounjaro (tirzepatide) is classified as a Prescription-Only Medicine under the Human Medicines Regulations 2012. That means no one can supply it without a valid prescription from an authorised prescriber. What the law does not say is that the prescriber must be your own GP, or that your GP must be consulted first. A GPhC-registered Independent Prescriber working at a regulated private service can assess your medical history, confirm eligibility, and issue a prescription entirely independently.
So the legal answer to this question is clear: you do not need GP sign-off to receive Mounjaro privately. What you do need is a thorough clinical assessment (BMI, relevant medical history, current medicines, weight-related conditions) carried out by a qualified prescriber who takes responsibility for that decision. The assessment is the requirement, not the letter from your surgery.
NHS England's guidance on weight-management injections covers the clinical context in more detail, and it's worth reading if you want to understand the landscape your prescriber is working within when they make these decisions.
Even though the law doesn't mandate it, the GPhC expects prescribers to act in patients' best interests, and in most cases that means telling your GP you've started a new prescription medicine. There are practical reasons behind this that go beyond box-ticking.
Tirzepatide slows gastric emptying, which affects how quickly other oral medicines are absorbed. If your GP is prescribing something else (a blood pressure tablet, a contraceptive pill, a thyroid medicine) they need to know about a new treatment that could change how those medicines behave. The NHS patient information on tirzepatide notes several interactions and conditions that require medical oversight.
There's also the broader picture of your care. If you visit your GP with a side effect, they're starting from scratch if Mounjaro isn't on your Summary Care Record. Notification closes that gap. At nume, GP notification follows our standard clinical process and is aligned with GPhC guidance, it's included because it genuinely protects patients, not to add friction.
You can request that your GP not be informed. Some people have complicated relationships with their surgery, concerns about insurance implications, or simply prefer to manage their health privately. These are legitimate choices. A prescriber must respect your autonomy, but they are also allowed to decline prescribing if they judge that keeping your GP in the dark would create unacceptable clinical risk. That's not a rejection; it's a prescriber doing their job properly.
If privacy is your priority, the most straightforward conversation is with the service before you start. Ask directly: what is your GP notification policy, and can I opt out? A good service will explain their position honestly rather than bury it in terms and conditions. For a fuller picture of how private assessment works without mandatory GP involvement, the Mounjaro without a doctor's referral page explains that route in more detail.
One practical note: if you're timing treatment around finances (a payday order, a quieter month, the week after the school holidays clear) the clinical review still happens before any prescription is issued, regardless of when you apply. The process doesn't change, but knowing that in advance means no surprises.
Responsible private prescribing doesn't replace GP care, it supplements it with its own safety infrastructure. At nume, every consultation is reviewed by a GPhC-registered Independent Prescriber before any prescription is issued. There's photo-ID verification, as explained on our page covering what happens if you're concerned about providing ID for Mounjaro, live weight confirmation on video, Summary Care Record checks where appropriate, and clinical re-review before every repeat order. If you're wondering how the visual side of that process works, our page on starting Mounjaro without submitting pictures sets out exactly what's required and why. These steps exist precisely because prescribing Mounjaro without a full picture of your health is not something any legitimate service will do lightly.
If you want to understand how the cost of private treatment compares across services and what that price actually covers, the Mounjaro price comparison guide is a useful reference. And if you're weighing up whether Mounjaro is the right route for you at all, our treatment overview sets out the options available.
Treatment that bypasses clinical assessment entirely is not a shortcut, it's a risk. The MHRA's Yellow Card scheme continues to receive reports of harm from medicines obtained without clinical oversight. A good prescriber, whether or not they notify your GP, is the non-negotiable part of safe treatment. Patients who have been through this process share their experiences on our reviews page for Mounjaro started without informing a GP, which gives a honest account of how it works in practice.
When you're ready to find out whether Mounjaro is clinically suitable for you, speak to our prescribers through a free consultation. No GP referral required.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.